Author Archives: admin_website

Abstract The Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) was developed with a consensus-based process using a combination of published data, and expert observations and opinions. In the short time since its release, numerous studies have validated the value of PI-RADS v2 but, as expected, have also identified a number of ambiguities […]

Abstract Context Magnetic resonance imaging (MRI)-targeted prostate biopsy (MRI-TB) may be an alternative to systematic biopsy for diagnosing prostate cancer. Objective The primary aims of this systematic review and meta-analysis were to compare the detection rates of clinically significant and clinically insignificant cancer by MRI-TB with those by systematic biopsy in men undergoing prostate biopsy […]

Abstract Immune checkpoint inhibitors (ICIs) are now used routinely to treat advanced or metastatic urothelial and renal cell carcinoma, among other cancers. Furthermore, multiple trials are currently exploring their role in adjuvant, neoadjuvant, and noninvasive (eg, high-grade non-muscle-invasive bladder cancer) settings. Consequently, urologists are increasingly confronted with patients who are on, have recently received, or […]

Abstract Context Bladder stones (BS) constitute 5% of urinary stones. Currently, there is no systematic review of their treatment. Objective To assess the efficacy (primary outcome: stone-free rate [SFR]) and morbidity of BS treatments. Evidence acquisition This systematic review was conducted in accordance with the European Association of Urology Guidelines Office. Database searches (1970–2019) were […]